"
Team:Hong Kong HKUST/hp/article/id
From 2013.igem.org
(Difference between revisions)
(Created page with "<html> <head> <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"> </script> <script type="text/javascript"> $(document).ready(function(){ $("ul.first ...") |
|||
| Line 8: | Line 8: | ||
$(this).find("ul").stop().fadeToggle(10); | $(this).find("ul").stop().fadeToggle(10); | ||
}); | }); | ||
| + | }); | ||
| + | </script> | ||
| + | <script> | ||
| + | $(document).ready(function(){ | ||
| + | |||
| + | // hide #back-top first | ||
| + | $("#back-top").hide(); | ||
| + | |||
| + | // fade in #back-top | ||
| + | $(function () { | ||
| + | $(window).scroll(function () { | ||
| + | if ($(this).scrollTop() > 100) { | ||
| + | $('#back-top').fadeIn(); | ||
| + | } else { | ||
| + | $('#back-top').fadeOut(); | ||
| + | } | ||
| + | }); | ||
| + | |||
| + | // scroll body to 0px on click | ||
| + | $('#back-top a').click(function () { | ||
| + | $('body,html').animate({ | ||
| + | scrollTop: 0 | ||
| + | }, 800); | ||
| + | return false; | ||
| + | }); | ||
| + | }); | ||
| + | |||
}); | }); | ||
</script> | </script> | ||
| Line 141: | Line 168: | ||
width:100%; | width:100%; | ||
} | } | ||
| - | ul.side-nav { | + | #back-top { |
| + | position: fixed; | ||
| + | top: 10%; | ||
| + | right: 2%; | ||
| + | } | ||
| + | #back-top a { | ||
| + | width: 108px; | ||
| + | display: block; | ||
| + | text-align: center; | ||
| + | font: 11px/100% Arial, Helvetica, sans-serif; | ||
| + | text-transform: uppercase; | ||
| + | text-decoration: none; | ||
| + | color: #bbb; | ||
| + | /* background color transition */ | ||
| + | -webkit-transition: 1s; | ||
| + | -moz-transition: 1s; | ||
| + | transition: 1s; | ||
| + | } | ||
| + | #back-top a:hover { | ||
| + | color: #ffffff; | ||
| + | } | ||
| + | |||
| + | #back-top span { | ||
| + | width: 65px; | ||
| + | height: 60px; | ||
| + | display: block; | ||
| + | margin-bottom: 7px; | ||
| + | background: #ddd url(up-arrow.png) no-repeat center center; | ||
| + | /* rounded corners */ | ||
| + | -webkit-border-radius: 15px; | ||
| + | -moz-border-radius: 15px; | ||
| + | border-radius: 15px; | ||
| + | /* background color transition */ | ||
| + | -webkit-transition: 1s; | ||
| + | -moz-transition: 1s; | ||
| + | transition: 1s; | ||
| + | } | ||
| + | #back-top a:hover span { | ||
| + | background-color: #777;margin-top:10px; | ||
| + | } | ||
| + | |||
| + | ul.side-nav, ul.side-nav1 { | ||
display: block; | display: block; | ||
list-style: none; | list-style: none; | ||
| Line 150: | Line 218: | ||
margin: 47px 0px 0px; | margin: 47px 0px 0px; | ||
} | } | ||
| - | ul.side-nav li.divider { | + | ul.side-nav1 h6 { |
| + | margin: 0px 0px 0px; | ||
| + | } | ||
| + | ul.side-nav li.divider, ul.side-nav1 li.divider { | ||
border-top: 1px solid #ddd; | border-top: 1px solid #ddd; | ||
} | } | ||
| Line 228: | Line 299: | ||
<body> | <body> | ||
| + | <p id="back-top" style=""display:none;> | ||
| + | <a href="#top"><span><img src="http://515alive.com/theme/img/up-arrow.png" style="width:90%;"><br><br>BACK TO TOP</span></a> | ||
| + | </p> | ||
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST><center><div id="kepala" style="height:121px;width:100%;"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;align:middle;"></div></center></a> | <a href=https://2013.igem.org/Team:Hong_Kong_HKUST><center><div id="kepala" style="height:121px;width:100%;"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;align:middle;"></div></center></a> | ||
<div id="cover"></div> | <div id="cover"></div> | ||
| Line 282: | Line 356: | ||
<div class="row"> | <div class="row"> | ||
<div class="two columns"> | <div class="two columns"> | ||
| - | + | <ul class="side-nav"> | |
| + | <li> | ||
| + | <h6>Indonesia</h6> | ||
| + | </li> | ||
| + | <li class="divider"></li> | ||
| + | <li> | ||
| + | <a href=#1>Overview</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href=#2>iGEM Participation</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href=#3>Biotechnology Funding</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href=#4>Perception</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href=#5>Research, People & Organizations</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href=#6>References</a> | ||
| + | </li> | ||
| + | |||
| + | |||
| + | |||
| + | </ul> | ||
| + | |||
| + | <ul class="side-nav1"> | ||
<li> | <li> | ||
<h6>Country Profile</h6> | <h6>Country Profile</h6> | ||
| Line 316: | Line 418: | ||
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
| - | <div class="nine columns"> | + | <div class="nine columns"><p id="1"></p> |
<h3>Overview</h3> | <h3>Overview</h3> | ||
This article will present information compiled from different online sources such as universities’ websites, newspaper, articles, and organizations’ websites. The information was searched both in English and Bahasa Indonesia. Information in Bahasa Indonesia was translated into English by Indonesian teammates. The general trend that we have notice from research is that information about synthetic biology in Indonesia is very limited. This might be due to the fact that not many people in Indonesia know about this subject. Information of biotechnology, however, was more abundant. Many companies and universities are participating in biotechnology development. Most of the research related to biotechnology focus on agriculture. In the future, following this trend in biotechnology, synthetic biology may also be used to improve agriculture in Indonesia. | This article will present information compiled from different online sources such as universities’ websites, newspaper, articles, and organizations’ websites. The information was searched both in English and Bahasa Indonesia. Information in Bahasa Indonesia was translated into English by Indonesian teammates. The general trend that we have notice from research is that information about synthetic biology in Indonesia is very limited. This might be due to the fact that not many people in Indonesia know about this subject. Information of biotechnology, however, was more abundant. Many companies and universities are participating in biotechnology development. Most of the research related to biotechnology focus on agriculture. In the future, following this trend in biotechnology, synthetic biology may also be used to improve agriculture in Indonesia. | ||
| Line 324: | Line 426: | ||
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
| - | <div class="nine columns"> | + | <div class="nine columns"><p id="2"></p> |
<h3>Participation in the iGEM Competition</h3> | <h3>Participation in the iGEM Competition</h3> | ||
| - | Out of 3100 universities in Indonesia, only three universities in Indonesia joined the iGEM competition. This reflects that very few people know about the iGEM competition and synthetic biology. The first Indonesian university that joined the iGEM competition is Bogor Agricultural University (BAU). This university joined the iGEM 2012 competition, but did not manage to get any awards. Two universities from Indonesia, Bandung Institute of Technology (ITB) and University of Indonesia (UI), have registered for the iGEM 2013 competition<br> | + | Out of 3100 universities in Indonesia, only three universities in Indonesia joined the iGEM competition. This reflects that very few people know about the iGEM competition and synthetic biology. The first Indonesian university that joined the iGEM competition is Bogor Agricultural University (BAU). This university joined the iGEM 2012 competition, but did not manage to get any awards. Two universities from Indonesia, Bandung Institute of Technology (ITB) and University of Indonesia (UI), have registered for the iGEM 2013 competition<br><br> |
| + | <center><img src="https://static.igem.org/mediawiki/igem.org/b/b2/Indonesia_igem_competition_1.png" style="width:90%;"></center><br> | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
| - | <div class="nine columns"> | + | <div class="nine columns"><p id="3"></p> |
<h3>Funding of Biotechnology</h3> | <h3>Funding of Biotechnology</h3> | ||
| - | In 2012, Indonesian Institute of Science (LIPI) received around US$ 14 million from the Indonesian government ("Dana 2012," 2013). This amount of money is only around 0.1% from national income. This year, in 2013, the government proposed that they would decrease the funding to LIPI by 9% from the total amount of 2012 funding (“Riset bioteknologi: Terkendala,” 2012). This is one of the reasons why biotechnology in Indonesia is far behind that the other Asian countries. In fact, the total funding per gross domestic product for Indonesia is around 0.07%. This value is smaller than those of Ethiopia (0.17% and Colombia (0.16%). Even with lack of government funding, some institutes and universities have the urge to develop biotechnology. There are already around 30 institutes and some universities in Indonesia that joined to develop biotechnology industry.<br> | + | <center><img src="https://static.igem.org/mediawiki/igem.org/e/e3/Indonesia_funding_of_biotechnology_1.png"></center><br> |
| + | In 2012, Indonesian Institute of Science (LIPI) received around US$ 14 million from the Indonesian government ("Dana 2012," 2013). This amount of money is only around 0.1% from national income. This year, in 2013, the government proposed that they would decrease the funding to LIPI by 9% from the total amount of 2012 funding (“Riset bioteknologi: Terkendala,” 2012). This is one of the reasons why biotechnology in Indonesia is far behind that the other Asian countries. In fact, the total funding per gross domestic product for Indonesia is around 0.07%. This value is smaller than those of Ethiopia (0.17% and Colombia (0.16%). Even with lack of government funding, some institutes and universities have the urge to develop biotechnology. There are already around 30 institutes and some universities in Indonesia that joined to develop biotechnology industry.<br><br> | ||
| + | <center><img src="https://static.igem.org/mediawiki/igem.org/e/ef/Indonesia_funding_of_biotechnology_2.png"></center><br> | ||
</div> | </div> | ||
| Line 341: | Line 446: | ||
<div class="row"> | <div class="row"> | ||
| - | <div class="nine columns"> | + | <div class="nine columns"><p id="4"></p> |
<h3>Perception of Synthetic Biology</h3> | <h3>Perception of Synthetic Biology</h3> | ||
| - | Bandung Institute of Technology (ITB) iGEM 2013 team conducted interviews with 5 random citizens in Indonesia. The interviewees came from different background. The interviews reveal that all of the interviewees did not know what synthetic biology meant. (R.N, 2013). The term synthetic biology did appear in newspapers and blogs, but no formal studies have been conducted to measure the perception of synthetic biology in Indonesia. Considering that not many people are fully understand with the term biotechnology, it seems like the concept synthetic biology, a relatively new field, is even less prevalent.<br> | + | Bandung Institute of Technology (ITB) iGEM 2013 team conducted interviews with 5 random citizens in Indonesia. The interviewees came from different background. The interviews reveal that all of the interviewees did not know what synthetic biology meant. (R.N, 2013). The term synthetic biology did appear in newspapers and blogs, but no formal studies have been conducted to measure the perception of synthetic biology in Indonesia. Considering that not many people are fully understand with the term biotechnology, it seems like the concept synthetic biology, a relatively new field, is even less prevalent.<br><br> |
| + | <center><img src="https://static.igem.org/mediawiki/igem.org/6/6a/Indonesia_perception_of_synthetic_biology_1.png"></center><br> | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
| - | <div class="nine columns"> | + | <div class="nine columns"><p id="5"></p> |
| - | <h3> | + | <h3>Research, People & Organizations</h3> |
<h5>Research</h5> | <h5>Research</h5> | ||
Scientists in Indonesia are actively conducting researches related to biology and biotechnology. For example, Indonesian Institute of Sciences Biotechnology Research Center (LIPI) has been conducting numerous researches related to biotechnology. It is probably these kinds of research institutes that will adopt synthetic biology techniques once it becomes more prevalent in Indonesia. | Scientists in Indonesia are actively conducting researches related to biology and biotechnology. For example, Indonesian Institute of Sciences Biotechnology Research Center (LIPI) has been conducting numerous researches related to biotechnology. It is probably these kinds of research institutes that will adopt synthetic biology techniques once it becomes more prevalent in Indonesia. | ||
<br><br> | <br><br> | ||
The following table summarizes some of the researches of LIPI<br><br> | The following table summarizes some of the researches of LIPI<br><br> | ||
| + | <center><img src="https://static.igem.org/mediawiki/igem.org/b/b3/Indonesia_research_people_and_organization_1.png"></center><br><br> | ||
| + | <h5>People</h5> | ||
| + | <center><img src=""></center><br><br> | ||
<h5>Organization</h5> | <h5>Organization</h5> | ||
There are several science organizations that could be found online. Some of them are in the field of biotechnology. None of them are explicitly related to synthetic biology. | There are several science organizations that could be found online. Some of them are in the field of biotechnology. None of them are explicitly related to synthetic biology. | ||
| Line 366: | Line 475: | ||
<p id="msk2">b. Innogene Kalbiotech: A subsidiary of Kalbe established as a basis to develop competence in biotechnology-</p><p id="msk4">based products. Innogene is actively involved in the acquisition, development and commercialization of products, one of the most prominent being TheraCIM, a monoclonal antibody for targeted cancer therapy.<br></p> | <p id="msk2">b. Innogene Kalbiotech: A subsidiary of Kalbe established as a basis to develop competence in biotechnology-</p><p id="msk4">based products. Innogene is actively involved in the acquisition, development and commercialization of products, one of the most prominent being TheraCIM, a monoclonal antibody for targeted cancer therapy.<br></p> | ||
<h5>Education</h5> | <h5>Education</h5> | ||
| - | There thousands of universities in Indonesia, but only some of them teach synthetic biology or biotechnology. Some universities don’t have biology course. Biotechnology and synthetic biology are taught mainly in big universities such as University of Indonesia and Gajah Mada University.<br> | + | There thousands of universities in Indonesia, but only some of them teach synthetic biology or biotechnology. Some universities don’t have biology course. Biotechnology and synthetic biology are taught mainly in big universities such as University of Indonesia and Gajah Mada University.<br><br> |
| + | <center><img src="https://static.igem.org/mediawiki/igem.org/b/ba/Indonesia_research_people_and_organization_4.png"></center><br> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div class="row"> | ||
| + | <div class="nine columns"><p id="6"></p> | ||
| + | |||
| + | <h3>References</h3> | ||
| + | <br> | ||
</div> | </div> | ||
</div> | </div> | ||
Revision as of 11:41, 24 September 2013
-
Indonesia
- Overview
- iGEM Participation
- Biotechnology Funding
- Perception
- Research, People & Organizations
- References
-
Country Profile
- Hong Kong
- China
- South Korea
- Japan
- Indonesia
- Comparison
Indonesia
Overview
This article will present information compiled from different online sources such as universities’ websites, newspaper, articles, and organizations’ websites. The information was searched both in English and Bahasa Indonesia. Information in Bahasa Indonesia was translated into English by Indonesian teammates. The general trend that we have notice from research is that information about synthetic biology in Indonesia is very limited. This might be due to the fact that not many people in Indonesia know about this subject. Information of biotechnology, however, was more abundant. Many companies and universities are participating in biotechnology development. Most of the research related to biotechnology focus on agriculture. In the future, following this trend in biotechnology, synthetic biology may also be used to improve agriculture in Indonesia.Participation in the iGEM Competition
Out of 3100 universities in Indonesia, only three universities in Indonesia joined the iGEM competition. This reflects that very few people know about the iGEM competition and synthetic biology. The first Indonesian university that joined the iGEM competition is Bogor Agricultural University (BAU). This university joined the iGEM 2012 competition, but did not manage to get any awards. Two universities from Indonesia, Bandung Institute of Technology (ITB) and University of Indonesia (UI), have registered for the iGEM 2013 competition
Funding of Biotechnology
In 2012, Indonesian Institute of Science (LIPI) received around US$ 14 million from the Indonesian government ("Dana 2012," 2013). This amount of money is only around 0.1% from national income. This year, in 2013, the government proposed that they would decrease the funding to LIPI by 9% from the total amount of 2012 funding (“Riset bioteknologi: Terkendala,” 2012). This is one of the reasons why biotechnology in Indonesia is far behind that the other Asian countries. In fact, the total funding per gross domestic product for Indonesia is around 0.07%. This value is smaller than those of Ethiopia (0.17% and Colombia (0.16%). Even with lack of government funding, some institutes and universities have the urge to develop biotechnology. There are already around 30 institutes and some universities in Indonesia that joined to develop biotechnology industry.
Perception of Synthetic Biology
Bandung Institute of Technology (ITB) iGEM 2013 team conducted interviews with 5 random citizens in Indonesia. The interviewees came from different background. The interviews reveal that all of the interviewees did not know what synthetic biology meant. (R.N, 2013). The term synthetic biology did appear in newspapers and blogs, but no formal studies have been conducted to measure the perception of synthetic biology in Indonesia. Considering that not many people are fully understand with the term biotechnology, it seems like the concept synthetic biology, a relatively new field, is even less prevalent.
Research, People & Organizations
Research
Scientists in Indonesia are actively conducting researches related to biology and biotechnology. For example, Indonesian Institute of Sciences Biotechnology Research Center (LIPI) has been conducting numerous researches related to biotechnology. It is probably these kinds of research institutes that will adopt synthetic biology techniques once it becomes more prevalent in Indonesia.The following table summarizes some of the researches of LIPI
People
Organization
There are several science organizations that could be found online. Some of them are in the field of biotechnology. None of them are explicitly related to synthetic biology.1. Indonesian Institute of Science (LIPI)
2. Indonesian Academy of Sciences (AIPI)
3. PT. Biotek Sarana Industri: A private industry that works in the field of biotechnology, chemical trading, agro
industry and pharmaceutical for pest control at commodity warehouse and farms.
4. PT. Jirona Agritama: A subsidiary of Biotech Group, which is engaged in trade in agricultural products
and plantations like oil palm, rubber, andcocoa, the main herbicide and insecticide products.
5. KALBE: A public pharmaceutical company, which focused on prescription pharmaceuticals, consumer health
products, nutritionals, and distribution and logistics. Kalbe established two institutes:
a. Stem Cell and Cancer Institute (SCI): SCI is a center for stem cell and cancer research, prepared to be the
basis for future therapy development to replace conventional drugs and therapy.
b. Innogene Kalbiotech: A subsidiary of Kalbe established as a basis to develop competence in biotechnology-
based products. Innogene is actively involved in the acquisition, development and commercialization of products, one of the most prominent being TheraCIM, a monoclonal antibody for targeted cancer therapy.
Education
There thousands of universities in Indonesia, but only some of them teach synthetic biology or biotechnology. Some universities don’t have biology course. Biotechnology and synthetic biology are taught mainly in big universities such as University of Indonesia and Gajah Mada University.
